Lyell Immunopharma 在第67届 ASH 年会中展示 Ronde-Cel 正在进行的试验新临床数据,显示大B细胞淋巴瘤患者中具有高比例的持久完全缓解

美股速递
Dec 08, 2025

Lyell Immunopharma 在第67届 ASH 年会中展示 Ronde-Cel 正在进行的试验新临床数据,显示大B细胞淋巴瘤患者中具有高比例的持久完全缓解

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10